Dublin, Oct. 18, 2021 (GLOBE NEWSWIRE) -- The "Automated and Rapid Microbiological Tests - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Amid the COVID-19 crisis, the global market for Automated and Rapid Microbiological Tests estimated at US$5.3 Billion in the year 2020, is projected to reach a revised size of US$7.6 Billion by 2026, growing at a CAGR of 6.1% over the analysis period.
GC/CRT (Clinical), one of the segments analyzed in the report, is projected to grow at a 7.4% CAGR to reach US$1 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the AISS (clinical) segment is readjusted to a revised 3.4% CAGR for the next 7-year period.
This segment currently accounts for a 10.4% share of the global Automated and Rapid Microbiological Tests market. The surge in the occurrences of STDs, such as GC/Chlamydia, HIV and Syphilis, has turned STD rapid tests into the most dynamic and vigorous segment of the market.
Growth in the global is set to be fueled by rising global prevalence of chronic infectious diseases, increasing food safety concerns, growing need for fast and easy diagnosis, rising public-private investments, funding, and research grants, and sustained technological advancements.
Continued technological advancements in terms of improved functionality, efficiency, efficacy, faster results, and accuracy are driving the adoption of microbial testing in academic institutes, research laboratories, hospitals, clinical laboratories, and biotechnology and pharmaceutical companies.
Rapid advancements in microbial testing help in overcoming limitations such as an extensive period of exposure to pathogenic strains and long procedural times associated with traditional testing methods. In addition, these tests serve as a cost-effective alternative to microbial identification by enabling reduction in the consumable cost per procedure.
The U.S. Market is Estimated at $2.1 Billion in 2021, While China is Forecast to Reach $709.2 Million by 2026
The Automated and Rapid Microbiological Tests market in the U.S. is estimated at US$2.1 Billion in the year 2021. The country currently accounts for a 37.1% share in the global market. China, the world's second largest economy, is forecast to reach an estimated market size of US$709.2 Million in the year 2026 trailing a CAGR of 8.6% through the analysis period.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5% CAGR while Rest of European market (as defined in the study) will reach US$766.1 Million by the end of the analysis period.
North America and Europe represent the leading regional markets, due to technological advancements related to rapid microbial testing, growing incidences of infectious diseases, and increasing food safety concerns. Asia-Pacific region presents considerable growth opportunities due to the rising healthcare expenditure and expanding initiatives for promotion of the use of advanced technologies in rapid microbiology testing.
ABCS (Clinical) Segment to Reach $530.3 Million by 2026
In the global ABCS (Clinical) segment, USA, Canada, Japan, China and Europe will drive the 2.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$372.2 Million in the year 2020 will reach a projected size of US$456.1 Million by the close of the analysis period.
China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$32.7 Million by the year 2026, while Latin America will expand at a 3.8% CAGR through the analysis period.
Key Topics Covered:
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Impact of COVID-19 Pandemic and Looming Global Recession
Clinical Microbiology Gains Prominence as Scientists Mobilize United Efforts to Find Ways to Detect, Treat & Vaccinate People Against the Novel Coronavirus: COVID-19 Tests Per Million Population by Country (As of 15 June 2021)
A New, 20-Minute Assay for COVID-19 Diagnosis
Automated and Rapid Microbiological Tests: An Introduction
Enabling Technologies of Automated & Rapid Microbiological Tests
Clinical Applications of Automated & Rapid Microbiological Tests
Applications in Non-Clinical Investigations
Global Market Prospects & Outlook
Evolutionary Battle against Microbes Drives Market Future
Clinical Applications Lead the Global Market for Automated and Rapid Microbiological Testing
Developed Regions Lead, Developing Economies to Boost Future Growth
Recent Market Activity
2. FOCUS ON SELECT PLAYERS (Total 77 Featured)
Abbott Molecular, Inc.
Beckman Coulter, Inc.
Becton Dickinson and Company
Bio-Rad Laboratories, Inc
Cellabs Pty Ltd
F. Hoffmann-La Roche AG
Meridian Bioscience, Inc.
OraSure Technologies, Inc.
Rapid Micro Biosystems, Inc.
Sekisui Diagnostics, LLC
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc.
3. MARKET TRENDS & DRIVERS
Rapid Diagnostics Bring in a Transformation to Clinical Testing Practices
Traditional Rapid Microbiological Tests Make Way for New, Probe Tests
Lab Automation Trend Augurs Well for Microbiological Testing Labs
Traditional Approaches Give Way to Modern Automated Microbiology Systems
Microbiology Laboratories Switch to Automation to Push Yields
Growing Incidence of Infectious Diseases to Fuel Demand for Rapid Microbiology Testing
Rising Prevalence of Respiratory Infections Drive Market Growth
Rise in Prevalence of COPD Augments Demand
Influenza Boosts Rapid Test Prospects
Rise in Pollution Levels Trigger Increase in Respiratory Diseases, Driving Opportunities for Automated Microbiology Tests
Sustained Threat of HIV and Sexually Transmitted Diseases Amplify Need for Rapid Microbiological Testing
Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
Home HIV Testing Emerges as a Lucrative Option
Advancements in Molecular Diagnostics Drive Market Growth
Emerging Technologies in Clinical Microbiology Diagnostics Aim at Faster Diagnosis
Automated Blood Culture Systems: The Gold Standard in the Fight against Bacteremia
Advancements in Molecular Diagnostics: A Boon for Rapid Microbiological Testing Market
Biotechnology: A Crucial Step Ahead in the Growing Popularity of Rapid Microbial Tests
Healthcare Needs of the World's Aging Population: Potential Opportunity in Store
Increase in Healthcare Spending in Emerging Markets to Propel Demand for Automated Microbiological Testing
Clinical Microbiology Market Benefits from Digitalization and Robotization Trend
Integration of Clinical Microbiology with Cloud Computing
Artificial Intelligence Holds Positive Implications for Automation of Clinical Microbiology
Point-of-Care Rapid Microbiological Testing: Yet to Realize Its Full Potential.
Technological Advancements to Drive the Automated Microbiology Testing Market
Focus on Safe and High-Quality Foods Propels Rapid Microbiological Testing
Foodborne Illness Outbreak Investigations in the US (2019 & 2020)
Impact of COVID-19 on Food Safety Testing Industry
Stringent Norms Necessitate Food Safety Testing
Food Microbiology Testing Market on a Growth Spree
Rapid and Automated Tests Emerge as an Attractive Solution
Leading Food Processors Exhibit Inclination Towards Rapid Microbiological Testing
Automation of Food Microbiology Labs
Poultry Industry Embraces Rapid Microbiological Testing Technologies
Rapid Microbial Testing in Dairy Industry
Real-time PCR/qPCR Technologies Fundamental in Food Safety Testing
Technical and Cost Related Hurdles Hamper the Microbiology Testing Market
Rapid Microbiological Testing Gains Significance in the Pharmaceutical Industry
Key Advantages of Rapid Microbiological Tests for Pharmaceutical Industry
Growing Importance of Rapid Microbiological Testing for Pharma Laboratories
Key RMM Technologies for Pharmaceutical Industry
Adoption of Rapid Methods for QC Microbiology in Biopharmaceuticals
Advancements in Rapid Microbiological Testing for Pharmaceutical Industry
Rapid Microbial Testing for Regenerative Medicine: An Emerging Space
Rapid Microbiological Methods and the Regulatory Environment in Drug Development Industry
FDA's Requirements for Validation of RMM
EMA's Guidance on Use of RMMs for Water Testing
Rapid Microbial Testing Emerges as an Important Means for Quality Control of Advanced Therapies
Antibiotic Resistant Bacteria Throws the Spotlight on Rapid Microbial Testing Tools
Antimicrobial Vulnerability Testing and Identification of Microbial strains
Role of Microscopy in Antimicrobial Susceptibility Testing
Rising Prominence of NAAT-Driven AST
Economic Factors Promise Growth for Rapid AST
Rapid Technologies Gain Momentum in Environment Testing Field
Deteriorating Quality of Water Throws Emphasis on Water Testing Services
Key Issues Confronting the Rapid Microbiological Tests Market
4. GLOBAL MARKET PERSPECTIVE
III. REGIONAL MARKET ANALYSIS
For more information about this report visit https://www.researchandmarkets.com/r/ecghu8
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900